Zuche Pharmaceuticals Private Limited
Yusuf Sarai, New Delhi, Delhi
GST No. 07AAACZ4393G1Z3
TrustSEAL Verified
Call 08048078786
SEND EMAIL
Product Details:
| Usage/Application | Personal |
| Form Of Medicines | Tablet |
| Packaging Type | Box |
| Quantity Per Pack | 1 tablet |
| Strength | Standard |
| Gender | female |
| Country of Origin | Made in India |
Product Details:
| Packaging Type | Strips, Carton, Bottles |
| Type Of Medicines | Allopathic |
| Dose | >600mg |
| Brand | zuche pharmaceuticals |
| Medicine Type | Allopathic |
| Strength (mg) | 800mg |
| Capacity (mg) | 800 mg |
Additional Information:
Product Details:
| Packaging Type | Strips, Carton |
| Type Of Medicines | Allopathic |
| Dose | <100 mg |
| Packing Size | 100 tablet |
| Application | Brain And Nervous System Medicines |
| Brand | z8uche pharmaceuticals |
| Dosage Form | Tablets |
| Certification | ISO, GMP |
| Strength (mg) | 25mg |
| Dose Or Strength (Mg) | 25mg |
| Grade standard | Medicine Grade |
Additional Information:
Product Details:
| Packaging Type | Carton, Strips |
| Type Of Medicines | Allopathic |
| Packing Size | 100 tablet per pack |
| Brand | zuche pharmaceuticals |
Additional Information:
Product Details:
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Shelf life | 1 year |
| Country of Origin | Made in India |
| packaging | Box |
| Dose | as prescribed |
Product Details:
| Usage | Commercial, Hospital |
| Dose | 1ml-5ml |
| Product Type | Finished Product |
| Packaging Size | 1ml ampoule |
| Sterilized | Yes |
| Brand | progesterone |
Additional Information:
Product Details:
| Form Of Medicines | Tablets |
| Dosage Form (If Applicable) | Tablets |
| Usage | Hospital |
| Application | anti malaria drug |
| Product Type | Finished Product |
| Type of Medicines | Allopathic |
Additional Information:
Product Details:
| Prescription/Non prescription | Prescription |
| Form | Tablet |
| Dosage Form | Capsule |
| Shelf life | 1 year |
| Capacity | 300 mg |
| Country of Origin | Made in India |
Additional Information:
Product Details:
| Dosage | As prescribed |
| Prescription Required | Yes |
| Country of Origin | Made in India |
| Shelf Life | 1 year |
| Strenght | standard |
| Form | tablet |
Product Details:
| Minimum Order Quantity | 10000 Pack |
| Packaging Type | Strips, Carton |
| Type Of Medicines | Allopathic |
| Dose | <100 mg |
| Brand | ZUCHE PHARMA |
| Product Type | Finished Product |
| Dosage Form | Tablets |
| Certification | GMP, FDA, ISO |
| Strength (mg) | 2MG |
| Strength | 0.2 mg |
| Number Of Tablets | 28 Tablets in Blister |
| Dose Or Strength (Mg) | 2MG |
| Usage | Commercial,Hospital |
Product Information
Estradiol valerate (Ess-trad-dy-ol val-er-rate) is a medicine which is used in Hormone Replacement Therapy in postmenopausal women who have had a hysterectomy..
Product Name: Estradiol Valerate Tablets 2 mg Tablets
Strength: Each Tablet Contains Estradiol Valerate Tablets 2 mg
Pack size: Each Unit Pack Contains 28 Tablets in Blister
Indications
Estradiol valerate contains a hormone which is similar to the hormoneoestrogen that is produced by the body. When women go through the menopause, levels of oestrogen become low. This leads to symptoms such as hot flushes, night sweats and dryness of the vagina. Estradiol valerate helps to replace the low levels of oestrogen which may help to relieve the symptoms of the menopause. This is known as hormone replacement therapy.
Estradiol valerate helps to treat the symptoms of the menopause but it may also increase the chances of getting certain types of cancers and certain heart or circulatory problems.
You and your prescriber will need to weigh up the risks and benefits of hormone replacement therapy. Your prescriber will review your treatment on a regular basis.
Women who are on hormone replacement therapy will be advised by their prescriber to watch out for any symptoms of breast, endometrial or ovarian cancer. They may be advised to regularly examine their breasts for any changes or lumps or report any unusual vaginal bleeding to their prescriber.
Treatment with hormone replacement therapy needs to be tailored to each individual. Sometimes a medicine containing the hormoneprogesterone will need to be taken as well as Estradiol valerate. For more information about different types of hormone replacement therapy, and the risks and benefits of having hormone replacement therapy, you should talk to your prescriber.
Common Name: Altadiol, Deladiol, Delestrogen, Estraval, Progynova, Valergen
Additional Information:
Product Details:
| Strength | 100mg |
| Packaging Size | 20*10 |
| Dose/Strength | 100mg |
| Prescription Required | Yes |
| Dosage Form | Capsule |
| Country of Origin | Made in India |
Additional Information:
Product Details:
| Packaging Type | Strips, Carton |
| Type Of Medicines | Allopathic |
| Dose | 101mg-250mg |
| Brand | zuche pharmaceuticals |
| Strength (mg) | 200mg |
Additional Information:
Product Details:
| Dose | 1ml-5ml |
| Usage | Hospital, Commercial |
| Application | Anti Infective & Common Disease Medicines |
| Portable | Yes |
| Sterilized | Yes |
Indications and Usage: Amikacin is an aminoglycoside antibiotic. It works by inhibiting the production of bacterial proteins, which causes bacterial cell death.
Pack Size: Amikacin Sulphate Injection is available in 2ml vial.
Common Name: aminoglycoside antibiotic injection
Additional Information:
Product Details:
| Minimum Order Quantity | 10000 Pack |
| Usage | Commercial, Hospital |
| Product Type | Finished Product |
| Dose/Strength | 20mg |
| Brand | zuche pharma |
Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, 4-hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a selective estrogen-receptor modulator. Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting
Product Name: Tamoxifen Citrate Tablets
Strength: Each Tablet contains 20 mg of Tamoxifen Citrate
Pack size: Each pack consists of 10 x10 Tablets
Indications
Metastatic Breast Cancer
Tamoxifen citrate is effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, tamoxifen citrate is an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen citrate therapy.
Adjuvant Treatment of Breast Cancer
Tamoxifen citrate is indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some tamoxifen citrate adjuvant studies, most of the benefit to date has been in the subgroup with four or more positive axillary nodes.
Tamoxifen citrate is indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation.
The estrogen and progesterone receptor values may help to predict whether adjuvant tamoxifen citrate therapy is likely to be beneficial. Tamoxifen citrate reduces the occurrence of contralateral breast cancer in patients receiving adjuvant tamoxifen citrate therapy for breast cancer.
Ductal Carcinoma in Situ (DCIS)
In women with DCIS, following breast surgery and radiation, tamoxifen citrate is indicated to reduce the risk of invasive breast cancer . The decision regarding therapy with tamoxifen citrate for the reduction in breast cancer incidence should be based upon an individual assessment of the benefits and risks of tamoxifen citrate therapy.
Current data from clinical trials support five years of adjuvant tamoxifen citrate therapy for patients with breast cancer.
Reduction in Breast Cancer Incidence in High Risk Women
Tamoxifen citrate is indicated to reduce the incidence of breast cancer in women at high risk for breast cancer. This effect was shown in a study of 5 years planned duration with a median follow-up of 4.2 years. Twenty-five percent of the participants received drug for 5 years. The longer-term effects are not known. In this study, there was no impact of tamoxifen on overall or breast cancer-related mortality
Tamoxifen citrate is indicated only for high-risk women. “High risk” is defined as women at least 35 years of age with a 5-year predicted risk of breast cancer ≥ 1.67%, as calculated by the Gail Model
Common Name: Nolvadex, Istubal, Valodex, and Genox.
Additional Information:
Product Details:
| Common Fluids | Normal Saline |
| Brand | alimta |
| Dose/Strength | 500mg |
| Quantity Per Pack | i vial tablet per pack |
Additional Information:
Product Details:
| Usage | Commercial, Clinical, Hospital |
| Dose/Strength | 1mg |
| Strength (mg) | 1mg |
| Brand | ANASTROZOLE |
Additional Information:
Product Details:
| Usage | Hospital, Commercial |
Additional Information:
Product Details:
| Usage | Hospital |
| Packaging Size | 100 tablet/pack |
Additional Information:
Product Details:
| Dose/Strength (ex. 1 mg or 1 ml) | 25mg |
| Usage | Hospital |
| Brand | atomoxetine capsules |
Additional Information: